Carolina Silva-Costa

Villejuif, 94805, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Corrigendum to "Nasal microbiota and clinical features in acute flu-like illness: COVID-19 status and long COVID follow-up" [International Journal of Infectious Diseases 162 (2026) 108196 https://doi.org/10.1016/j.ijid.2025.108196].

Corrigendum to "Nasal microbiota and clinical features in acute flu-like illness: COVID-19 status and long COVID follow-up" [International Journal of Infectious Diseases 162 (2026) 108196 https://doi.org/10.1016/j.ijid.2025.108196].

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: February 21, 2026

Subclinical cholestasis is a hallmark of gut dysbiosis causing resistance to cancer immunotherapy.

Subclinical cholestasis is a hallmark of gut dysbiosis causing resistance to cancer immunotherapy.

Journal: Cancer cell

Published: September 01, 2025

Nasal microbiota and clinical features in acute flu-like illness: COVID-19 status and long COVID follow-up.

Nasal microbiota and clinical features in acute flu-like illness: COVID-19 status and long COVID follow-up.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: August 16, 2025

Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling.

Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling.

Journal: Nature medicine

Published: August 12, 2025

Benzodiazepines interfere with the efficacy of pembrolizumab-based cancer immunotherapy. Results of a nationwide cohort study including over 50,000 participants with advanced lung cancer.

Benzodiazepines interfere with the efficacy of pembrolizumab-based cancer immunotherapy. Results of a nationwide cohort study including over 50,000 participants with advanced lung cancer.

Journal: Oncoimmunology

Published: July 04, 2025

Soluble MAdCAM-1 as a biomarker in metastatic renal cell carcinoma.

Soluble MAdCAM-1 as a biomarker in metastatic renal cell carcinoma.

Journal: Nature medicine

Published: April 19, 2025

Surrogate markers of intestinal dysfunction associated with survival in advanced cancers.

Surrogate markers of intestinal dysfunction associated with survival in advanced cancers.

Journal: Oncoimmunology

Published: April 07, 2025

Oncobiomics: Leveraging Microbiome Translational Research in Immuno-Oncology for Clinical-Practice Changes.

Oncobiomics: Leveraging Microbiome Translational Research in Immuno-Oncology for Clinical-Practice Changes.

Journal: Biomolecules

Published: January 26, 2025

Acyl-CoA binding protein for the experimental treatment of anorexia.

Acyl-CoA binding protein for the experimental treatment of anorexia.

Journal: Science translational medicine

Published: August 14, 2024

State of the art and the future of microbiome-based biomarkers: a multidisciplinary Delphi consensus.

State of the art and the future of microbiome-based biomarkers: a multidisciplinary Delphi consensus.

Journal: The Lancet. Microbe

Published: February 09, 2024

Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients.

Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients.

Journal: Cancer cell

Published: January 27, 2024

Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma.

Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma.

Journal: Oral oncology

Published: June 24, 2023

Showing 1-12 of 27

Last Updated: 09/26/2026